Evidence map›Paper›PMID 36231008›Full record

ArticleCells2022

Visceral Adipose Tissue E2F1-miRNA206/210 Pathway Associates with Type 2 Diabetes in Humans with Extreme Obesity.

Nitzan Maixner, Yulia Haim, Matthias Blüher, Vered Chalifa-Caspi, Isana Veksler-Lublinsky, Nataly Makarenkov, Uri Yoel, Nava Bashan, Idit F Liberty, Ivan Kukeev and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Exosomes Derived from E2F1International journal of nanomedicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Nitzan MaixnerDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.
Yulia HaimDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany.ORCID 0000-0003-0208-2065
Vered Chalifa-CaspiIlse Katz Institute for Nanoscale Science & Technology, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Isana Veksler-LublinskyDepartment of Software & Information Systems Engineering, Faculty of Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.ORCID 0000-0002-4251-6158
Nataly MakarenkovDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.
Uri YoelDiabetes, Endocrinology and Bariatric services, Soroka University Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0003-3805-3565
Nava BashanDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.
Idit F LibertyDiabetes, Endocrinology and Bariatric services, Soroka University Medical Center, Beer-Sheva 84105, Israel.
Ivan KukeevDiabetes, Endocrinology and Bariatric services, Soroka University Medical Center, Beer-Sheva 84105, Israel.
Oleg DukhnoDiabetes, Endocrinology and Bariatric services, Soroka University Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0001-5995-4237
Dan LevyNational Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.ORCID 0000-0003-0719-0305
Assaf RudichDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84103, Israel.ORCID 0000-0002-1366-1444
Ben-Gurion University of the Negev · ILSoroka Medical Center · ILHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2MicroRNAsE2F1 Transcription FactorGlucoseHEK293 CellsHumansInsulinIntra-Abdominal FatObesityE2F1 protein, humanE2F1 Transcription FactorGlucoseInsulinMicroRNAsMIRN206 microRNA, humandys-glycemiaE2F1miR-206miR-210-5pobesity

Identifiers

PMID36231008
PMCPMC9562862
OpenAlexW4298003042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.